Most studies have been carried out in chronic schizophrenia patients, but recent papers have described reduced peripheral BDNF levels in high clinical risk groups and patients with the first episode of schizophrenia (Martinez-Cengotitabengoa et al. 2016; Heitz et al. 2018). This evidence concerns the gene BDNF and schizophrenia.